Trust Company
FBT icon

Trust Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Trust Company’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-14
Closed -$3.47K – 926
2026
Q2 		$3.47K Hold
14
– – ﹤0.01% 510
2026
Q1 		$2.81K Hold
14
– – ﹤0.01% 508
2025
Q4 		$2.89K Buy
+14
New +$2.8K ﹤0.01% 505

Other funds holding FBT

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Arlington Financial Advisors
Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TriaGen Wealth Management
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Ocean Park Asset Management
Ocean Park Asset Management Santa Monica, California $1.65B AUM 1.83% 1-Year Est. Return

Trust Company's FBT Position: Q3 2026 in Review

Trust Company sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 14 shares — an estimated $3.47K sold.

Trust Company first reported a position in FBT in Q4 2025 and held it in 3 quarters. The position peaked at $3.47K in Q2 2026. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Trust Company reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • Trust Company sold 14 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $3.47K.
  • Trust Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and held it in 3 quarters.
  • Trust Company's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.47K in Q2 2026.
  • 98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.